Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

INCY

Incyte (INCY)

Incyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INCY
DateTimeSourceHeadlineSymbolCompany
07/05/20116:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
07/05/20116:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
07/05/20117:15AMZacksEli Lilly Provides R&D Update - Analyst BlogNASDAQ:INCYIncyte Corporation
06/23/20114:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
06/17/20114:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
06/15/20115:03PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:INCYIncyte Corporation
06/15/20115:03PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:INCYIncyte Corporation
06/15/20112:07PMZacksRisk-Reward Balanced at Incyte - Analyst BlogNASDAQ:INCYIncyte Corporation
06/13/20119:12AMZacksIncyte Gives Lead Candidate Data - Analyst BlogNASDAQ:INCYIncyte Corporation
06/11/201112:30PMBusiness WireIncyte Reports Additional Analyses of Symptomatic Improvement & Quality of Life with Ruxolitinib (INC424) in Patients with My...NASDAQ:INCYIncyte Corporation
06/10/20115:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
06/08/20116:30AMZacksNovartis Presents INC424 Data - Analyst BlogNASDAQ:INCYIncyte Corporation
06/07/20115:29PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
06/07/20116:15AMZacksIncyte Seeks FDA approval - Analyst BlogNASDAQ:INCYIncyte Corporation
06/06/20118:00AMBusiness WireIncyte Submits New Drug Application for Ruxolitinib in Myelofibrosis to the US Food and Drug AdministrationNASDAQ:INCYIncyte Corporation
06/04/20116:54PMDow Jones NewsUPDATE: Novartis, Incyte Drug Effective In Rare Blood CancerNASDAQ:INCYIncyte Corporation
06/04/20112:59PMDow Jones NewsNovartis, Incyte Drug Effective In Rare Blood CancerNASDAQ:INCYIncyte Corporation
06/04/20112:30PMBusiness WireIncyte Announces Ruxolitinib (INC424) Shows Significant Clinical Benefit for Myelofibrosis Patients in Two Phase III Studies ...NASDAQ:INCYIncyte Corporation
05/31/20112:14PMDow Jones NewsCORRECT: IN THE PIPELINE: Melanoma In Focus At Cancer MeetingNASDAQ:INCYIncyte Corporation
05/31/201111:29AMDow Jones NewsIN THE PIPELINE: Melanoma In Focus At Annual Cancer MeetingNASDAQ:INCYIncyte Corporation
05/25/20114:40PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:INCYIncyte Corporation
05/24/20114:15PMBusiness WireIncyte to Present at Upcoming Investor ConferencesNASDAQ:INCYIncyte Corporation
05/23/20114:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/23/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
05/19/20114:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY